Literature DB >> 32308203

Patients with respiratory symptoms are at greater risk of COVID-19 transmission.

Rongrong Yang1, Xien Gui1, Yong Xiong2.   

Abstract

Entities:  

Keywords:  COVID-19; Cough; Emerging infectious disease; Virus shedding

Mesh:

Year:  2020        PMID: 32308203      PMCID: PMC7151456          DOI: 10.1016/j.rmed.2020.105935

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


× No keyword cloud information.
The situation with the ongoing epidemic of coronavirus disease 2019 (COVID-19) that started in Wuhan, China, continued to rapidly evolve. As of 10 March 2020, China had confirmed 80 754 cases of COVID-19 and there had been 3136 deaths. Except for China, 109 other nations have reported 32 555 cases and 878 deaths. The clinical and laboratory characteristics of hospitalized COVID-19 patients were described [1,2]. Cough is one of the most common symptoms at onset of illness [3]. Here, we described the differences in characteristics of nasopharyngeal swab detection between patients with and without respiratory symptoms. The 82 COVID-19 patients were divided into respiratory symptoms group (26 cases) and non-respiratory symptoms group (56 cases). The two groups were comparable in gender (11 [42.3%] men vs 20 [35.7%] men; P = 0.567) and age (median age, 56 years [IQR, 35–65] vs 51 years [IQR, 36–64]; P = 0.398). Compared with patients who did not presented with respiratory symptoms, those patients who presented with cough were more likely to have longer duration of COVID-19 positive testing by nasopharyngeal swab (median duration, 17 days [IQR, 12–23] vs 13 days [IQR, 6–20]; P = 0.041), and have more stable results of COVID-19 testing by nasopharyngeal swab (24 [92.3%] vs 38 [67.9%], P = 0.016). We believe that patients with respiratory symptoms are more harmful to close contacts. First, the virus can be shed explosively from the COVID-19 patients’ upper respiratory tract into the air through coughing. Second, the duration of virus shedding from nasopharynx was longer. It is an effective precaution to stop droplets spreading by hand or with towel when coughing. After coughing, the importance of frequent and proper hand hygiene should be emphasized. Moreover, strict precautions must be observed when handling the towel contaminated with spittle. One encouraging finding is that the results of nasopharyngeal swabs are more stable in patients with cough symptoms. The incidence of nasopharyngeal swabs testing shown as negative and positive fluctuating repeatedly is less, which provides a basis for clinicians to better grasp the appropriate time to cancel quarantine based on the results of asopharyngeal swabs.

Fund program

Supported by , Grant NO. TFJC2018002.

Declaration of competing interest

We declare no competing interests.
  3 in total

1.  Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Authors:  Jin-Jin Zhang; Xiang Dong; Yi-Yuan Cao; Ya-Dong Yuan; Yi-Bin Yang; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-02-27       Impact factor: 13.146

2.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

3.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

  3 in total
  4 in total

1.  SARS-CoV-2 detection, viral load and infectivity over the course of an infection.

Authors:  Kieran A Walsh; Karen Jordan; Barbara Clyne; Daniela Rohde; Linda Drummond; Paula Byrne; Susan Ahern; Paul G Carty; Kirsty K O'Brien; Eamon O'Murchu; Michelle O'Neill; Susan M Smith; Máirín Ryan; Patricia Harrington
Journal:  J Infect       Date:  2020-06-29       Impact factor: 6.072

2.  Determining the communicable period of SARS-CoV-2: A rapid review of the literature, March to September 2020.

Authors:  Mina Park; Colleen Pawliuk; Tribesty Nguyen; Amanda Griffitt; Linda Dix-Cooper; Nadia Fourik; Martin Dawes
Journal:  Euro Surveill       Date:  2021-04

3.  Alternative SARS-CoV-2 detection protocol from self-collected saliva for mass diagnosis and epidemiological studies in low-incoming regions.

Authors:  Luana Prado Rolim de Oliveira; Aline Diniz Cabral; Andreia Moreira Dos Santos Carmo; Adriana Feliciano Duran; Diego Marin Fermino; Glaucia Raquel Luciano Veiga; Beatriz da Costa Aguiar Alves; Carla Moreira Santana; Felipe Baena Garcia; Edmar Silva Santos; Felipe Trovalim Jordão; Andressa Moreira Siqueira; Ivana Barros de Campos; Daniela Rodrigues Colpas; Fernanda Nascimento Almeida; Fernando Luiz Affonso Fonseca; Márcia Aparecida Sperança
Journal:  J Virol Methods       Date:  2021-11-27       Impact factor: 2.014

4.  SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia.

Authors:  Olumayokun A Olajide; Victoria U Iwuanyanwu; Oyinkansola D Adegbola; Alaa A Al-Hindawi
Journal:  Mol Neurobiol       Date:  2021-10-28       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.